These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8795611)

  • 1. Cholinesterase inhibition in Parkinson's disease.
    Hutchinson M; Fazzini E
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):324-5. PubMed ID: 8795611
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease dementia--a first step?
    Press DZ
    N Engl J Med; 2004 Dec; 351(24):2547-9. PubMed ID: 15590960
    [No Abstract]   [Full Text] [Related]  

  • 3. [Good evidence for benefits of cholinesterase inhibitors in Parkinson dementia is still missing].
    Larsson A
    Lakartidningen; 2006 May 10-16; 103(19):1537; discussion 1537-8. PubMed ID: 16805251
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacotherapy of Parkinson disease dementia and Lewy body dementia.
    Gauthier S
    Front Neurol Neurosci; 2009; 24():135-139. PubMed ID: 19182471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse Lewy body disease: a common yet misdiagnosed dementia in which neuroleptics may be contraindicated.
    Scarbrough TJ
    Tenn Med; 1998 Feb; 91(2):58-60. PubMed ID: 9478123
    [No Abstract]   [Full Text] [Related]  

  • 6. Rivastigmine for dementia associated with Parkinson's disease.
    Harada CN; Shega JW; Sachs GA
    N Engl J Med; 2005 Mar; 352(13):1387; author reply 1387. PubMed ID: 15800242
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dementia--common, difficult to treat complication in Parkinson disease. Early diagnosis valuable--cholinesterase inhibitors can give better quality of life].
    Lökk J; Winblad B
    Lakartidningen; 2006 Feb 15-21; 103(7):451-5. PubMed ID: 16535872
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for cholinesterase-inhibitor therapy for dementia associated with Parkinson's disease.
    Boeve BF
    Lancet Neurol; 2005 Mar; 4(3):137-8. PubMed ID: 15721821
    [No Abstract]   [Full Text] [Related]  

  • 9. Modest facilitation on memory in dementia with combined lecithin and anticholinerestase treatment.
    Kaye WH; Sitaram N; Weingartner H; Ebert MH; Smallberg S; Gillin JC
    Biol Psychiatry; 1982 Feb; 17(2):275-80. PubMed ID: 7074185
    [No Abstract]   [Full Text] [Related]  

  • 10. The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia.
    Werber EA; Rabey JM
    J Neural Transm (Vienna); 2001; 108(11):1319-25. PubMed ID: 11768630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia.
    Maidment ID; Fox C; Boustani M
    Acta Psychiatr Scand; 2005 Jun; 111(6):403-9. PubMed ID: 15877706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase inhibitors for Parkinson's disease dementia.
    Maidment I; Fox C; Boustani M
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004747. PubMed ID: 16437494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibitors for treatment of dementia associated with Parkinson's disease.
    Cummings JL
    J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):903-4. PubMed ID: 15965192
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of dementia associated with Parkinson's disease.
    Emre M
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S457-61. PubMed ID: 18267283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acetylcholinesterase inhibitors for dementia--an update].
    Anghelescu I; Heuser I
    MMW Fortschr Med; 2007 May; 149 Suppl 2():76-8. PubMed ID: 17724973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rivastigmine against dementia in Parkinson disease?].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2007 Nov; 127(22):2973; author reply 2973-4. PubMed ID: 18026256
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenetic mechanisms of dementia in the older patients with Parkinson's diseases].
    Chukhlovina ML
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):79-82. PubMed ID: 25202788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia in Parkinson's disease.
    Hanagasi HA; Tufekcioglu Z; Emre M
    J Neurol Sci; 2017 Mar; 374():26-31. PubMed ID: 28088312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dementia in Parkinson's disease].
    Halvorsen Ø; Tysnes OB
    Tidsskr Nor Laegeforen; 2007 Oct; 127(19):2517-20. PubMed ID: 17925819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.